PATENT CLAIM ANALYSIS

Application Number: 15964381
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "250000"]

Abstract:
A compound of general formula I, wherein X, R 1 -R 4  take various meanings, for use in the treatment of cancer.

Claim (Index 2):
The compound according to  claim 1  selected from formula Ia or Ib, or a pharmaceutically acceptable salt or ester thereof: wherein: X is \u2014NH\u2014 or \u2014O\u2014; R 1  is \u2014OH or \u2014CN; R 2  is a \u2014C(\u2550O)R a  group; R 3  is hydrogen or a \u2014OR b  group; R 4  is selected from \u2014CH 2 OH, \u2014CH 2 OC(\u2550O)R c , \u2014CH 2 NH 2 , and \u2014CH 2 NHProt NH ; R a  is selected from hydrogen, substituted or unsubstituted C 1 -C 12  alkyl, substituted or unsubstituted C 2 -C 12  alkenyl, and substituted or unsubstituted C 2 -C 12  alkynyl; R b  is selected from substituted or unsubstituted C 1 -C 12  alkyl, substituted or unsubstituted C 2 -C 12  alkenyl, and substituted or unsubstituted C 2 -C 12  alkynyl; R c  is selected from substituted or unsubstituted C 1 -C 12  alkyl, substituted or unsubstituted C 2 -C 12  alkenyl, and substituted or unsubstituted C 2 -C 12  alkynyl; and Prot NH  is a protecting group for amino.

Metadata:
- Claim Count in Document: 150.0
- Percentile: 91.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14901314', '12899410', '15499532', '13397195', '12883883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7826289139323678
- 35 USC 102 Novelty (BERT): 0.5325685032663666
- Combined Prediction Score: 0.7576228728657677
- Mean Citation Score: 329.556092
- Max Citation Score: 341.7664
- Similarity Product: 266.98096237945555

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test